Venture startup

Who invested in Sayre Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2017, from 1 source

Latest round
Venture, $8.0MSept 2017
Investors
1
See who backed them

The rounds

  1. Sept 2017
    Venture$8.0M

    Source recorded

Everyone who backed them

InnoVen CapitalVenture debt1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Sayre Therapeutics

Who invested in Sayre Therapeutics?

Sayre Therapeutics's investors include InnoVen Capital.

How much has Sayre Therapeutics raised?

Sayre Therapeutics has raised $8.0M across 1 round since 2017.

When did Sayre Therapeutics last raise?

Sayre Therapeutics's most recent round was a Venture of $8.0M in Sept 2017.

What was Sayre Therapeutics's biggest round?

Its most recent round, $8.0M in Sept 2017, is also its largest on record.

Who backed Sayre Therapeutics first?

Sayre Therapeutics's first round on record, in Sept 2017, was backed by InnoVen Capital.

What stage is Sayre Therapeutics at?

Sayre Therapeutics's latest named round is a Venture, in Sept 2017.

Companies like Sayre Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.